Adenosine hypothesis of schizophrenia–opportunities for pharmacotherapy

D Boison, P Singer, HY Shen, J Feldon, BK Yee - Neuropharmacology, 2012 - Elsevier
Pharmacotherapy of schizophrenia based on the dopamine hypothesis remains
unsatisfactory for the negative and cognitive symptoms of the disease. Enhancing N-methyl …

Adenosine receptors as drug targets

BB Fredholm - Experimental cell research, 2010 - Elsevier
There are four adenosine receptors, A1, A2A, A2B and A3, together forming a defined
subgroup of G protein coupled receptors. They are well conserved and widely expressed …

Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the …

LF Agnati, S Ferré, C Lluis, R Franco, K Fuxe - Pharmacological reviews, 2003 - ASPET
The molecular basis for the known intramembrane receptor/receptor interactions among G
protein-coupled receptors was postulated to be heteromerization based on receptor subtype …

[HTML][HTML] A ketogenic diet improves cognition and has biochemical effects in prefrontal cortex that are dissociable from hippocampus

AR Hernandez, CM Hernandez, K Campos… - Frontiers in aging …, 2018 - frontiersin.org
Age-related cognitive decline has been linked to a diverse set of neurobiological
mechanisms, including bidirectional changes in proteins critical for neuron function …

[HTML][HTML] Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death

G Burnstock, A Verkhratsky - Cell death & disease, 2010 - nature.com
The purinergic signalling system, which uses purines and pyrimidines as chemical
transmitters, and purinoceptors as effectors, is deeply rooted in evolution and development …

Release of adenosine and ATP during ischemia and epilepsy

N Dale, BG Frenguelli - Current neuropharmacology, 2009 - ingentaconnect.com
Eighty years ago Drury & Szent-Gyorgyi described the actions of adenosine, AMP (adenylic
acid) and ATP (pyrophosphoric or diphosphoric ester of adenylic acid) on the mammalian …

Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease

K Xu, E Bastia, M Schwarzschild - Pharmacology & therapeutics, 2005 - Elsevier
In the pursuit of improved treatments for Parkinson's disease (PD), the adenosine A2A
receptor has emerged as an attractive nondopaminergic target. Based on the compelling …

[HTML][HTML] Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice

T Li, G Ren, T Lusardi, A Wilz, JQ Lan… - The Journal of …, 2008 - Am Soc Clin Investig
Astrogliosis is a pathological hallmark of the epileptic brain. The identification of
mechanisms that link astrogliosis to neuronal dysfunction in epilepsy may provide new …

CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents

R Cipriani, P Villa, G Chece, C Lauro… - Journal of …, 2011 - Soc Neuroscience
The chemokine CX3CL1 and its receptor CX3CR1 are constitutively expressed in the
nervous system. In this study, we used in vivo murine models of permanent middle cerebral …

[HTML][HTML] Exogenous ketone supplements reduce anxiety-related behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk rats

C Ari, Z Kovács, G Juhasz, C Murdun… - Frontiers in molecular …, 2016 - frontiersin.org
Nutritional ketosis has been proven effective for seizure disorders and other neurological
disorders. The focus of this study was to determine the effects of ketone supplementation on …